logo
Select company
Select metric
$ -176.76MEarning Before Interest & Taxes (EBIT)
VS
Market
6
Sector
12
Industry
16
History
-
$ 23.95Close
$ 6.43 - $ 27.76 52-Week Range
Ticker Information

Ticker

ZBIO

Company Name

ZENAS BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZENAS BIOPHARMA INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZBIO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -176.76M
12/31/2024$ -156.56M
12/31/2023$ -36.82M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZENAS BIOPHARMA INC's latest trailing twelve months (TTM) EBIT stands at $ -36.82M.
  • Over the past 5 years, ZENAS BIOPHARMA INC's average EBIT has been $ -123.38M.
  • The median EBIT for ZENAS BIOPHARMA INC during this period was $ -156.56M
  • ZENAS BIOPHARMA INC reached its highest EBIT over the past 5 years at $ -36.82M.
  • The lowest EBIT recorded by ZENAS BIOPHARMA INC in the same timeframe $ -176.76M

ZENAS BIOPHARMA INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
ABUS : ARBUTUS BIOPHARMA CORP $ -54.14MQURE : UNIQURE NV $ -135.06MNUVB : NUVATION BIO INC $ -202.21MVIR : VIR BIOTECHNOLOGY INC $ -549.95MBCYC : BICYCLE THERAPEUTICS PLC $ -248.02MIMNM : IMMUNOME INC $ -212.39MRLAY : RELAY THERAPEUTICS INC $ -311.55MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MTSHA : TAYSHA GENE THERAPIES INC $ -92.64MALMS : ALUMIS INC $ -236.08M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ZBIO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -176.76M

Minimum

Jun 30, 2025

$ -36.82M

Maximum

Dec 31, 2023

$ -123.38M

Average

$ -156.56M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M